We are an international pharmaceutical company based in Parma, with more 80 years of experience and a strong focus on research, development, production and the commercialization of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas. Chiesi combines the pioneering spirit of an SME (Small and Medium Enterprise) with the ambitions of a multinational. How do we succeed in doing this? Thanks to our team of passionate and resourceful professionals. Each and every day, they build on our exceptional results in a focused, credible and humble manner. We call this the Chiesi spirit. The Belgian Chiesi site (affiliate of the Chiesi Group SA) was established in 2010. Our enthusiastic team consists of more than 70 people and is particularly focused on bringing our treatments to the Belgian patients. In close consultation with patients and medical professionals, we make our contribution to the improvement of health care.


The Shift helpt leden gebruik maken van het globaal kader van de UN Sustainable Development Goals om hun maatschappelijke ambities in kaart te brengen.

3. Good health

This sustainability program is in line with Chiesi’s values and mission to combine commitment to results with integrity, operating in a responsible manner from a social and environmental point of view. We want to use business as a force for good and in May 2019 we became the first global pharmaceutical company to reach the B Corp certification. (Find more here about Chiesi and the B Corp certification). We also commit to contributing to the Sustainable Development Goals (SDGs) promoted by the United Nations.